Debut Unveils AI-powered Platform to Discover Novel Ingredients
Last update on Jan 31, 2025
Debut announced the launch of BeautyORB™, an AI-powered innovation engine that provides a new way to discover novel ingredients for 'best-in-class claims' for beauty brands. It will create two novel, peak-performing biotech ingredients each year.The genomics-based AI platform, which is on par with pharmaceutical-grade technology, has already fueled the creation of ingredients addressing inflammaging, epidermal barrier repair and longevity, with brightening, anti-aging and scalp care ingredients already in the pipeline.
New Ingredients via Computational Compound Prediction
BeautyORB™, a discovery engine discovers new ingredients by screening 50 billion molecules for their ability to turn on cellular pathways within skin, a process that has never previously been possible in beauty. Debut's AI platform has already identified three novel, patented ingredients that achieve the highest beauty standards including scientifically-proven, clinically-tested, and 100% bio-based ingredients that beat existing benchmarks. These ingredients include:
- DermCeutical InflammagePRO™: Decreases inflammatory markers, supports the skin barrier, and enhances elasticity. The company claims it is 15X better than niacinamide
- DermCeutical Barrier RepairPRO™: Defends the skin against damage from environmental aggressors. The company claims 30% better than vitamin C for skin damage repair
- DermCeutical LongevityPRO™: Decreases markers of cellular senescence and helps maintain healthy skin cells. The company claims it is 2X better than vitamin C for skin health
"With our advanced AI platform and understanding of skin biology, we can rapidly create brand new ingredients through computational compound prediction. This allows us to activate specific aspects of skin biology while also discovering new or improved cellular pathways for enhanced clinical claims," said Joshua Britton, Ph.D, founder and CEO of Debut.
Don't Have to Rely on Existing Ingredients to Test Against Specific Claims
"We don't have to rely on an array of existing ingredients to test against specific claims, and we don't have to go into the field to find rare ingredients in plants. All this can be done at the click of a button, cutting out years from the innovation cycle and accessing ingredients that no one has seen before. We can turn on and off molecular pathways differently and use AI to discover what molecules can affect those pathways. The result is a rich, proven and growing pipeline of novel ingredients with the strongest clinical results for our customers, allowing brands to win on product performance rather than marketing".
"With BeautyORB™, we can develop ingredients that have the targeted responses we seek, using the same technology to find ingredients that fight disease. Our tool is another key step in the convergence of pharma and beauty. We are thrilled to partner with the industry leading contract manufacturer KDC/one to create finished products of the highest quality, in tandem with Debut's custom formulation business, BiotechXBeautyLabs™, to achieve our mission of reinventing product performance with the safest sustainability credentials. Our KDC/one partnership sets the stage for a global biomanufacturing revolution in beauty," said Britton.
BeautyORB™ is the latest tool to emerge from Debut's ongoing commitment to play its role in the beauty industry's shift to biotech, creating a community of future-forward brands and product innovators that solve existing and emerging consumer needs. Using generative AI, BeautyORB™ delivers:
- More than 50 billion molecule possibilities
- 30,000 genes tested per molecule using omics technology
- 25,000 genes tested per second
- 21,000 molecules screened in silico per second for deep learning
- 200+ new biological pathways tested per molecule
- Over 60 million data points, with 100 million over the next 12 months
Source
Debut